CLINICAL_TRIALS
trial_result
· 2017-03-15
Clinical Trial Update: 8 Week Study to Evaluate and Compare the Efficacy and Tolerability of MAXCLARITY II and MURAD To Treat Acne [Phase 4]
Summary
A Phase 4 study comparing MAXCLARITY II and MURAD for acne vulgaris has completed, with results posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Stiefel, a GSK Company | Conditions: Acne Vulgaris | Phase 4 | Status: COMPLETED | Results posted: 2017-03-15